Tag: CMC

Case Study: Managing the Regulatory Filing Impacts of Hold Time and Storage Changes In today’s highly regulated pharmaceutical landscape, the implications of hold times and storage changes can significantly influence…

Assessing the Regulatory Impact of Multiple Strength Scale-Up: A Practical Approach In the fast-paced environment of pharmaceutical manufacturing, scaling up a product to multiple strengths can lead to unforeseen challenges.…

Understanding the Impact of Process Analytical Technology Changes on Regulatory Filings With the increasing complexity of pharmaceutical manufacturing processes, the integration of Process Analytical Technology (PAT) presents both opportunities and…

Understanding the Regulatory Filing Challenges of Process Analytical Technology Changes In the regulated pharmaceutical industry, changes to Process Analytical Technology (PAT) can have significant implications for regulatory submissions. Various stakeholders,…

Preparing for Inspector-Ready Evidence in Scale-Up Regulatory Filings In the pharmaceutical manufacturing environment, scale-up processes are a critical juncture that can significantly impact regulatory compliance and filing strategies. When transitioning…

Strategies for Developing Inspection-Ready Documentation for Scale-Up Regulatory Filings In the realm of pharmaceutical manufacturing, scale-up processes are critical for bringing successful products to market. However, common pitfalls in documentation…

Understanding the Regulatory Filing Impact of Changes During Scale-Up In pharmaceutical manufacturing, post-approval change management can significantly affect regulatory filings and product compliance. Understanding the implications of these changes is…

Addressing the Regulatory Filing Challenges of Post-Approval Change Management The pharmaceutical manufacturing landscape is heavily influenced by the need for compliance and risk management regarding post-approval changes. As organizations strive…

Managing Regulatory Filing Commitments Post First Commercial Batch The transition from clinical trials to commercial manufacturing presents a critical juncture in the pharmaceutical industry. Frequently, companies face challenges related to…

Managing Regulatory Filing Changes Following the First Commercial Batch In the lifecycle of a pharmaceutical product, the transition from development to commercial manufacturing poses significant regulatory challenges. A common scenario…

Understanding the Regulatory Filing Impact When Scaling Up Manufacturing Sites Pharmaceutical companies frequently face challenges when transitioning to a new commercial manufacturing site, especially concerning regulatory compliance and filing requirements.…

Understanding the Regulatory Filing Impacts When Scaling Up Manufacturing Pharmaceutical companies face a multitude of challenges when scaling up manufacturing processes, particularly regarding regulatory requirements. The need for efficient regulatory…